Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
Launched by UNIVERSITY HOSPITAL, GHENT · Jun 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to detect problems with growth in twin pregnancies, specifically looking for conditions called fetal growth restriction (FGR). The researchers will assess the growth of the babies at two important times during pregnancy: at 21 weeks and again at 30 weeks. They will also collect a blood sample from the mother to check for exposure to air pollution and other markers that indicate how well the placenta is functioning. By using special ultrasounds, they hope to spot any issues with the placenta early on. After the babies are born, the team will look at the placenta and umbilical cord blood to see how they relate to the babies' heart health.
To be eligible for this study, women must be at least 18 years old and have a twin pregnancy that is 21 weeks along (give or take two weeks). The study is not for women who are pregnant with three or more babies, have certain heart or genetic issues with the fetus, or have specific health problems themselves, like diabetes or autoimmune diseases. Participants can expect to undergo several tests during their pregnancy and after delivery, helping researchers learn more about how to better identify and address growth issues in twins.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton or dichorionic twin pregnancy
- • Pregnant women 21 weeks ( ± 2 weeks) of gestation at the first visit
- • Women ≥ 18 years
- Exclusion Criteria:
- • Women pregnant of multiples of higher order (≥3 siblings) Monochorionic twin pregnancy
- • Fetal arrhythmia
- • Known fetal congenital or genetic abnormalities
- • Any suspicion of congenital fetal anomalies that might influence fetal cardiac function
- • Pre-existing maternal hypertensive disease
- • Autoimmune disease including systemic lupus erythematosus
- • History of stillbirth
- • Diabetes mellitus (mother)
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Leuven, , Belgium
Eindhoven, , Netherlands
Patients applied
Trial Officials
Kristien Roelens
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials